300404 Stock Overview
Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Boji Medical Technology Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥9.69 |
| 52 Week High | CN¥11.49 |
| 52 Week Low | CN¥5.03 |
| Beta | -0.060 |
| 1 Month Change | 3.42% |
| 3 Month Change | 37.45% |
| 1 Year Change | 9.86% |
| 3 Year Change | 8.18% |
| 5 Year Change | 18.20% |
| Change since IPO | 147.45% |
Recent News & Updates
We Don’t Think Boji Medical TechnologyLtd's (SZSE:300404) Earnings Should Make Shareholders Too Comfortable
Nov 02
A Piece Of The Puzzle Missing From Boji Medical Technology Co.,Ltd.'s (SZSE:300404) 39% Share Price Climb
Oct 08Recent updates
We Don’t Think Boji Medical TechnologyLtd's (SZSE:300404) Earnings Should Make Shareholders Too Comfortable
Nov 02A Piece Of The Puzzle Missing From Boji Medical Technology Co.,Ltd.'s (SZSE:300404) 39% Share Price Climb
Oct 08Boji Medical TechnologyLtd's (SZSE:300404) Profits Appear To Have Quality Issues
May 01Further Upside For Boji Medical Technology Co.,Ltd. (SZSE:300404) Shares Could Introduce Price Risks After 35% Bounce
Mar 06Shareholder Returns
| 300404 | CN Life Sciences | CN Market | |
|---|---|---|---|
| 7D | -1.4% | -4.2% | -3.5% |
| 1Y | 9.9% | -19.0% | 10.9% |
Return vs Industry: 300404 exceeded the CN Life Sciences industry which returned -19% over the past year.
Return vs Market: 300404 underperformed the CN Market which returned 10.9% over the past year.
Price Volatility
| 300404 volatility | |
|---|---|
| 300404 Average Weekly Movement | 8.6% |
| Life Sciences Industry Average Movement | 10.2% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 300404 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300404's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 1,091 | Tingchun Wang | www.bojicro.com |
Boji Medical Technology Co.,Ltd. provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally. It offers pre-clinical research, clinical research, and other consulting services.
Boji Medical Technology Co.,Ltd. Fundamentals Summary
| 300404 fundamental statistics | |
|---|---|
| Market cap | CN¥3.68b |
| Earnings (TTM) | CN¥44.59m |
| Revenue (TTM) | CN¥753.20m |
82.5x
P/E Ratio4.9x
P/S RatioIs 300404 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300404 income statement (TTM) | |
|---|---|
| Revenue | CN¥753.20m |
| Cost of Revenue | CN¥521.03m |
| Gross Profit | CN¥232.17m |
| Other Expenses | CN¥187.57m |
| Earnings | CN¥44.59m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.12 |
| Gross Margin | 30.82% |
| Net Profit Margin | 5.92% |
| Debt/Equity Ratio | 6.9% |
How did 300404 perform over the long term?
See historical performance and comparisonDividends
0.1%
Current Dividend Yield9%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 19:53 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Boji Medical Technology Co.,Ltd. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Siao Ye | Everbright Securities Co. Ltd. |
| Kehan Meng | Haitong International Research Limited |